Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Clearance of HIV infection in a perinatally infected infant.
|
N Engl J Med
|
1995
|
3.76
|
2
|
Translocation of the glucose transporter (GLUT4) to the cell surface in permeabilized 3T3-L1 adipocytes: effects of ATP insulin, and GTP gamma S and localization of GLUT4 to clathrin lattices.
|
J Cell Biol
|
1992
|
2.71
|
3
|
The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system.
|
Proc Natl Acad Sci U S A
|
1999
|
2.48
|
4
|
Quantitative polymerase chain reaction does not improve preoperative prostate cancer staging: a clinicopathological molecular analysis of 121 patients.
|
J Urol
|
1996
|
2.25
|
5
|
Human immunodeficiency virus type 1 T-cell tropism is determined by events prior to provirus formation.
|
J Virol
|
1990
|
2.11
|
6
|
Molecular cloning and tissue distribution of PHAS-I, an intracellular target for insulin and growth factors.
|
Proc Natl Acad Sci U S A
|
1994
|
2.02
|
7
|
Swelling-induced release of glutamate, aspartate, and taurine from astrocyte cultures.
|
J Neurosci
|
1990
|
1.98
|
8
|
Genotyping steroid 21-hydroxylase deficiency: hormonal reference data.
|
J Clin Endocrinol Metab
|
1983
|
1.77
|
9
|
Microfilter paper method for 17 alpha-hydroxyprogesterone radioimmunoassay: its application for rapid screening for congenital adrenal hyperplasia.
|
J Clin Endocrinol Metab
|
1977
|
1.69
|
10
|
Scatter factor and hepatocyte growth factor: activities, properties, and mechanism.
|
Cell Growth Differ
|
1992
|
1.56
|
11
|
GLUT-4 NH2 terminus contains a phenylalanine-based targeting motif that regulates intracellular sequestration.
|
J Cell Biol
|
1993
|
1.35
|
12
|
HLA linkage and B14, DR1, BfS haplotype association with the genes for late onset and cryptic 21-hydroxylase deficiency.
|
Am J Hum Genet
|
1981
|
1.35
|
13
|
Clinical and functional effects of mutations in the DAX-1 gene in patients with adrenal hypoplasia congenita.
|
J Clin Endocrinol Metab
|
1999
|
1.31
|
14
|
Prenatal diagnosis of congenital adrenal hyperplasia (21-hydroxylase deficiency) by HLA typing.
|
Lancet
|
1979
|
1.30
|
15
|
In vivo pathogenic properties of two clonal human immunodeficiency virus type 1 isolates.
|
J Virol
|
1995
|
1.24
|
16
|
Etoposide metabolites enhance DNA topoisomerase II cleavage near leukemia-associated MLL translocation breakpoints.
|
Biochemistry
|
2001
|
1.16
|
17
|
A pilot newborn screening for congenital adrenal hyperplasia in Alaska.
|
J Clin Endocrinol Metab
|
1982
|
1.10
|
18
|
Low plasma androgens in women with systemic lupus erythematosus.
|
Arthritis Rheum
|
1987
|
1.08
|
19
|
"Acquired" adrenal hyperplasia with 21-hydroxylase deficiency is not the same genetic disorders as congenital adrenal hyperplasia.
|
J Clin Endocrinol Metab
|
1979
|
1.05
|
20
|
Missense mutations cluster within the carboxyl-terminal region of DAX-1 and impair transcriptional repression.
|
J Clin Endocrinol Metab
|
2001
|
1.04
|
21
|
Late-onset steroid 21-hydroxylase deficiency: a variant of classical congenital adrenal hyperplasia.
|
J Clin Endocrinol Metab
|
1982
|
1.02
|
22
|
Electromyogram-triggered neuromuscular stimulation for improving the arm function of acute stroke survivors: a randomized pilot study.
|
Arch Phys Med Rehabil
|
1998
|
1.02
|
23
|
Human health and chemical mixtures: an overview.
|
Environ Health Perspect
|
1998
|
1.01
|
24
|
The relationship between luteinizing hormone and estradiol secretion in female precocious puberty: evaluation by sensitive gonadotropin assays and the leuprolide stimulation test.
|
J Clin Endocrinol Metab
|
1993
|
1.01
|
25
|
Prostate-specific targeting using PSA promoter-based lentiviral vectors.
|
Cancer Gene Ther
|
2001
|
1.00
|
26
|
Cryptic 21-hydroxylase deficiency in families of patients with classical congenital adrenal hyperplasia.
|
J Clin Endocrinol Metab
|
1980
|
1.00
|
27
|
Serum androgen concentrations in neonates and young infants with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
|
Clin Endocrinol (Oxf)
|
1979
|
0.99
|
28
|
Late onset 21-hydroxylase deficiency and HLA in the Ashkenazi population: a new allele at the 21-hydroxylase locus.
|
Hum Immunol
|
1980
|
0.98
|
29
|
Amniotic fluid concentrations of delta 5 and delta 4 steroids in fetuses with congenital adrenal hyperplasia due to 21 hydroxylase deficiency and in anencephalic fetuses.
|
J Clin Endocrinol Metab
|
1980
|
0.98
|
30
|
Highly efficient and consistent gene transfer into dendritic cells utilizing a combination of ultraviolet-irradiated adenovirus and poly(L-lysine) conjugates.
|
Cancer Res
|
1998
|
0.96
|
31
|
Regulation of the expression of the prostate-specific antigen by claudin-7.
|
J Membr Biol
|
2003
|
0.96
|
32
|
Genetic and hormonal characterization of cryptic 21-hydroxylase deficiency.
|
J Clin Endocrinol Metab
|
1981
|
0.94
|
33
|
Adrenocortical tumor in a patient with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
|
Pediatrics
|
1981
|
0.92
|
34
|
Excitatory amino acid-stimulated uptake of 22Na+ in primary astrocyte cultures.
|
J Neurosci
|
1989
|
0.91
|
35
|
The 21-hydroxylase activity in the glomerulosa and fasciculata of the adrenal cortex in congenital adrenal hyperplasia.
|
J Clin Endocrinol Metab
|
1981
|
0.91
|
36
|
Inherited congenital adrenal hyperplasia in the rabbit is caused by a deletion in the gene encoding cytochrome P450 cholesterol side-chain cleavage enzyme.
|
Endocrinology
|
1993
|
0.89
|
37
|
SULT1A1 catalyzes 2-methoxyestradiol sulfonation in MCF-7 breast cancer cells.
|
Carcinogenesis
|
2000
|
0.89
|
38
|
Studies of the C-21 and C-19 steroids and HLA genotyping in siblings and parents of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
|
J Clin Endocrinol Metab
|
1980
|
0.89
|
39
|
New studies of the 11 beta-hydroxylase and 18-hydroxylase enzymes in the hypertensive form of congenital adrenal hyperplasia.
|
J Clin Endocrinol Metab
|
1980
|
0.88
|
40
|
Dihydrotestosterone and its relationship to testosterone in infancy and childhood.
|
J Clin Endocrinol Metab
|
1979
|
0.88
|
41
|
Selegiline as an adjunct to conventional levodopa therapy in Parkinson's disease. Experience with this type B monoamine oxidase inhibitor in 200 patients.
|
Arch Neurol
|
1989
|
0.88
|
42
|
The variable bone scan appearances of nonosteogenic fibroma of bone.
|
Clin Nucl Med
|
1981
|
0.87
|
43
|
The effect of technology on the caring attributes of an international sample of nurses.
|
Int J Nurs Stud
|
2001
|
0.87
|
44
|
Developmental expression of insulin-regulatable glucose transporter GLUT-4.
|
Am J Physiol
|
1992
|
0.86
|
45
|
An update of congenital adrenal hyperplasia.
|
Recent Prog Horm Res
|
1981
|
0.85
|
46
|
In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines.
|
Cancer
|
1996
|
0.85
|
47
|
HLA genotypes and HLA-linked genetic markers in Italian patients with classical 21-hydroxylase deficiency.
|
Hum Genet
|
1981
|
0.84
|
48
|
Hypothalamic-pituitary-adrenal function following cranial irradiation.
|
Horm Res
|
1997
|
0.84
|
49
|
Congenital adrenal hypoplasia: two new cases.
|
J Endocrinol Invest
|
1983
|
0.82
|
50
|
Dog safety in rural China: children's sources of safety information and effect on knowledge, attitudes, and practices.
|
Accid Anal Prev
|
2013
|
0.81
|
51
|
Hormonal phenotype and HLA-genotype in families of patients with congenital adrenal hyperplasia (21-hydroxylase deficiency).
|
Pediatr Res
|
1979
|
0.81
|
52
|
Pitfalls of prenatal diagnosis of 21-hydroxylase deficiency congenital adrenal hyperplasia.
|
Ann N Y Acad Sci
|
1985
|
0.81
|
53
|
Induction of cytochrome P450 1B1 in MDA-MB-231 human breast cancer cells by non-ortho-substituted polychlorinated biphenyls.
|
Toxicol In Vitro
|
2002
|
0.81
|
54
|
Antepartum diagnosis of goitrous hypothyroidism by fetal ultrasonography and amniotic fluid thyrotropin concentration.
|
J Clin Endocrinol Metab
|
1984
|
0.81
|
55
|
[Changes in TGF-beta 1 and type I, III procollagen gene expression in keloid and hypertrophic scar].
|
Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi
|
1999
|
0.81
|
56
|
The hypothalamic-pituitary-adrenal axis in partial (late-onset) 21-hydroxylase deficiency.
|
J Clin Endocrinol Metab
|
1988
|
0.80
|
57
|
Caring attributes, professional self concept and technological influences in a sample of Registered Nurses in eleven countries.
|
Int J Nurs Stud
|
1999
|
0.80
|
58
|
In vivo cancer gene therapy with a recombinant interleukin-2 adenovirus vector.
|
Cancer Gene Ther
|
1996
|
0.79
|
59
|
Pitfalls of prenatal diagnosis of 21-hydroxylase deficiency congenital adrenal hyperplasia.
|
J Clin Endocrinol Metab
|
1985
|
0.79
|
60
|
Nonsalt-losing congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase deficiency with normal glomerulosa function.
|
J Clin Endocrinol Metab
|
1983
|
0.79
|
61
|
Mutations in the type II 3 beta-hydroxysteroid dehydrogenase gene in a patient with classic salt-wasting 3 beta-hydroxysteroid dehydrogenase deficiency congenital adrenal hyperplasia.
|
Pediatr Res
|
1993
|
0.79
|
62
|
Selegiline use to prevent progression of Parkinson's disease. Experience in 22 de novo patients.
|
Arch Neurol
|
1989
|
0.79
|
63
|
Cobalt chromium-based biodegradable polymer sirolimus-eluting stent: rationale, evidence and clinical experience.
|
Minerva Cardioangiol
|
2015
|
0.79
|
64
|
Efficacy of intracytoplasmic sperm injection using intentionally cryopreserved epididymal spermatozoa.
|
Hum Reprod
|
1996
|
0.78
|
65
|
Feasibility of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent in patients with complex anatomical and clinical scenarios.
|
Minerva Cardioangiol
|
2015
|
0.78
|
66
|
Natural immune reactivity-associated therapeutic response in patients with metastatic renal cell carcinoma receiving tumor-infiltrating lymphocytes and interleukin-2-based therapy.
|
J Immunother Emphasis Tumor Immunol
|
1996
|
0.77
|
67
|
In vitro modulation of the invasive and metastatic potentials of human renal cell carcinoma by interleukin-2 and/or interferon-alpha gene transfer.
|
Cancer
|
1994
|
0.77
|
68
|
Combined bromocriptine and growth hormone (GH) treatment in GH-deficient children with macroprolactinoma in situ.
|
J Clin Endocrinol Metab
|
1992
|
0.76
|
69
|
A child found to be HIV positive shortly after birth appears now to be clear of the infection.
|
Nurs Times
|
1995
|
0.76
|
70
|
Characterization of two novel homozygous missense mutations involving codon 6 and 259 of type II 3beta-hydroxysteroid dehydrogenase (3betaHSD) gene causing, respectively, nonsalt-wasting and salt-wasting 3betaHSD deficiency disorder.
|
J Clin Endocrinol Metab
|
2000
|
0.76
|
71
|
Insulin stimulates the release of a subset of GPI-anchored proteins in a G-protein independent manner.
|
Mol Membr Biol
|
2000
|
0.76
|
72
|
Molecular basis of congenital adrenal hyperplasia in two siblings with classical nonsalt-losing 3 beta-hydroxysteroid dehydrogenase deficiency.
|
J Clin Endocrinol Metab
|
1994
|
0.76
|
73
|
Hypothalamic-pituitary-gonadal axis function in pubertal male and female siblings with glucocorticoid-treated nonsalt-wasting 3 beta-hydroxysteroid dehydrogenase deficiency congenital adrenal hyperplasia.
|
J Clin Endocrinol Metab
|
1993
|
0.76
|
74
|
Studies of 3 beta-hydroxysteroid dehydrogenase genes in infants and children manifesting premature pubarche and increased adrenocorticotropin-stimulated delta 5-steroid levels.
|
J Clin Endocrinol Metab
|
1996
|
0.76
|
75
|
A new model of phycobilisome in Spirulina platensis.
|
Sci China C Life Sci
|
1999
|
0.76
|
76
|
Newborn screening for congenital adrenal hyperplasia with special reference to screening in Alaska.
|
Ann N Y Acad Sci
|
1985
|
0.76
|
77
|
Fabrication of Boron-Doped CVD Diamond Microelectrodes.
|
Anal Chem
|
1998
|
0.76
|
78
|
Prenatal diagnosis and treatment of congenital adrenal hyperplasia.
|
J Pediatr Endocrinol
|
1995
|
0.76
|
79
|
Delayed puberty in males with chronic renal failure.
|
Kidney Int
|
1980
|
0.76
|
80
|
First Whole-Genome Sequence of a Clinical Isolate of Multidrug-Resistant Mycobacterium bovis BCG.
|
Genome Announc
|
2014
|
0.75
|
81
|
A new compound heterozygous frameshift mutation in the type II 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) gene causes salt-wasting 3 beta-HSD deficiency congenital adrenal hyperplasia.
|
J Clin Endocrinol Metab
|
1996
|
0.75
|
82
|
[Expression of proliferating cell nuclear antigen and tumor suppressor gene P53 in mucoepidermoid carcinoma of salivary glands].
|
Zhonghua Kou Qiang Yi Xue Za Zhi
|
1996
|
0.75
|
83
|
[Alteration of CD44v3 and CD44v6 expression in oral premalignant epithelia].
|
Zhonghua Kou Qiang Yi Xue Za Zhi
|
1999
|
0.75
|
84
|
[Proliferating cell nuclear antigen (PCNA) in oral leukoplakia].
|
Zhonghua Kou Qiang Yi Xue Za Zhi
|
1995
|
0.75
|
85
|
Hormonal studies in obligate heterozygotes and siblings of patients with 11 beta-hydroxylase deficiency congenital adrenal hyperplasia.
|
J Clin Endocrinol Metab
|
1980
|
0.75
|
86
|
Practical advances in cortisol and dehydroepiandrosterone sulfate radioimmunoassay using the microfilter paper method.
|
J Lab Clin Med
|
1980
|
0.75
|
87
|
Evidence of a steroidogenic enzyme gene dose effect on adrenal gene expression in hereditary rabbit congenital adrenal hyperplasia.
|
Pediatr Res
|
1994
|
0.75
|
88
|
Recovery of adrenal function after treatment of adrenocortical carcinoma with o,p'-DDD.
|
Clin Endocrinol (Oxf)
|
1984
|
0.75
|
89
|
[The tensor fascia lata racket shape myocutaneous island flap].
|
Zhonghua Zheng Xing Wai Ke Za Zhi
|
2001
|
0.75
|
90
|
HLA typing of amniotic cells: the prenatal diagnosis of congenital adrenal hyperplasia (21-OH-deficiency type).
|
Transplant Proc
|
1979
|
0.75
|
91
|
Peer reviewed: evaluating impacts of hormonally active agents in the environment.
|
Environ Sci Technol
|
2000
|
0.75
|
92
|
Cloning, sequencing, and enzymatic activity of an inducible aldo-keto reductase from Chinese hamster ovary cells.
|
Adv Exp Med Biol
|
1997
|
0.75
|
93
|
Polycystic ovary syndrome and congenital adrenal hyperplasia.
|
Clin Endocrinol (Oxf)
|
1984
|
0.75
|
94
|
Births averted in Singapore during 1966-1975.
|
Singap Stat Bull
|
1977
|
0.75
|
95
|
Copper(II) ion induced monolayer formation of p-tert-butylthiacalix[4]arene at the air-water interface.
|
Spectrochim Acta A Mol Biomol Spectrosc
|
2001
|
0.75
|
96
|
Swelling-induced membrane transport changes in astrocytes.
|
Acta Physiol Scand Suppl
|
1989
|
0.75
|
97
|
Comparison of adrenocorticotropin and adrenal steroid responses to corticotropin-releasing hormone versus metyrapone testing in patients with hypopituitarism.
|
Pediatr Res
|
1994
|
0.75
|
98
|
[Investigation on an ancient edition of On Five Viscera unearthed in Dunhuang-Turfan].
|
Zhonghua Yi Shi Za Zhi
|
1995
|
0.75
|
99
|
Detection of heterozygote of 21-hydroxylase deficiency.
|
Lancet
|
1980
|
0.75
|
100
|
Recurrence of Cushing's disease in childhood after radiotherapy-induced remission.
|
Am J Dis Child
|
1987
|
0.75
|
101
|
Changes of intracellular Na(+) concentration in erythrocytes caused by pulsed electrical field.
|
Sci China C Life Sci
|
1997
|
0.75
|
102
|
L-deprenyl, a MAO-B inhibitor, as an adjunct to conventional L-dopa therapy in Parkinson's disease: experience in 200 patients.
|
Adv Neurol
|
1990
|
0.75
|
103
|
Assembly and structure of neurofilaments isolated from bovine spinal cord.
|
Sci China C Life Sci
|
1999
|
0.75
|
104
|
Quenching of fluorescence in membrane protein by hypocrellin B.
|
Sci China C Life Sci
|
1997
|
0.75
|
105
|
Evaluation of a pen device for self-administration of recombinant human FSH in clomiphene citrate-resistant anovulatory women undergoing ovulation induction.
|
Reprod Biomed Online
|
2004
|
0.75
|
106
|
[Basaloid squamous cell carcinoma: clinical pathological and immunohistochemical study].
|
Zhonghua Kou Qiang Yi Xue Za Zhi
|
1998
|
0.75
|
107
|
Caring in context: caring practices in a sample of Hong Kong nurses.
|
Contemp Nurse
|
1998
|
0.75
|
108
|
Adenovirus-mediated interleukin-2 production by tumors induces growth of cytotoxic tumor-infiltrating lymphocytes against human renal cell carcinoma.
|
J Immunother
|
1998
|
0.75
|
109
|
Empty sella syndrome in childhood.
|
Pediatr Neurol
|
1989
|
0.75
|
110
|
Gene therapy: principles and potential.
|
Cancer Surv
|
1995
|
0.75
|